Keywords: eu, approves, erbitux, scchn, german, drugmaker, merck

EU approves Erbitux for SCCHN

Article | 10 April 2006

Print This

German drugmaker Merck KGaA says that the European Commission has granted a marketing authorization extension to its cancer drug Erbitux ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in